Chunhua Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Chunhua Zhu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Aihua Zhang
Department of Pediatric Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, China
1 shared publication - Danyang Tian
Department of Physiology, Hebei Medical University, 361 Zhongshan Road Shijiazhuang, Shijiazhuang 050017, China
1 shared publication Guixia Ding
Department of Nephrology, Nanjing Children's Hospital, Nanjing Medical University, Nanjing, China
1 shared publication- Liqun Ren
Department of Geriatrics Medicine, Zhongda Hospital of Southeast University, Nanjing, China
1 shared publication - Mi Bai
Department of Nephrology, Children’s Hospital of Nanjing Medical University, Nanjing, China
1 shared publication - Ruochen Che
Department of Nephrology, Nanjing Children's Hospital, Nanjing Medical University, Nanjing, China
1 shared publication
Latest Publications
- 1 April 2016
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 310 (7) , F669-F678
Reactive oxygen species-initiated autophagy opposes aldosterone-induced podocyte injury
Evidence has demonstrated that aldosterone (Aldo) is involved in the development and progression of chronic kidney diseases. The purpose of the present study was to investigate the role of autophagy in Aldo-induced podocyte damage and the underlying mechanism. Mouse podocytes were treated with Aldo in the presence or absence of 3-methyladenine and N-acetylcysteine. Cell apoptosis was investigated by detecting annexin V conjugates, apoptotic bodies, caspase-3 activity, and alterations of the podocyte protein nephrin. Autophagy was evaluated by measuring the expressions of light chain 3, p62, beclin-1, and autophagy-related gene 5. Aldo (10−7 mol/l) induced podocyte apoptosis, autophagy, and downregulation of nephrin protein in a time-dependent manner. Aldo-induced apoptosis was further promoted by the inhibition of autophagy via 3-methyladenine and autophagy-related gene 5 small interfering RNA pretreatment. Moreover, Aldo time dependently increased ROS generation, and H2O2 (10−4 mol/l) application remarkably elevated podocyte autophagy. After treatment with N-acetylcysteine, the autophagy induced by Aldo or H2O2 was markedly attenuated, suggesting a key role of ROS in mediating autophagy formation in podocytes. Inhibition of ROS could also lessen Aldo-induced podocyte injury. Taken together, our findings suggest that ROS-triggered autophagy played a protective role against Aldo-induced podocyte injury, and targeting autophagy in podocytes may represent a new therapeutic strategy for the treatment of podocytopathy.
- 1 April 2016
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 310 (7) , F669-F678
Reactive oxygen species-initiated autophagy opposes aldosterone-induced podocyte injury
Evidence has demonstrated that aldosterone (Aldo) is involved in the development and progression of chronic kidney diseases. The purpose of the present study was to investigate the role of autophagy in Aldo-induced podocyte damage and the underlying mechanism. Mouse podocytes were treated with Aldo in the presence or absence of 3-methyladenine and N-acetylcysteine. Cell apoptosis was investigated by detecting annexin V conjugates, apoptotic bodies, caspase-3 activity, and alterations of the podocyte protein nephrin. Autophagy was evaluated by measuring the expressions of light chain 3, p62, beclin-1, and autophagy-related gene 5. Aldo (10−7 mol/l) induced podocyte apoptosis, autophagy, and downregulation of nephrin protein in a time-dependent manner. Aldo-induced apoptosis was further promoted by the inhibition of autophagy via 3-methyladenine and autophagy-related gene 5 small interfering RNA pretreatment. Moreover, Aldo time dependently increased ROS generation, and H2O2 (10−4 mol/l) application remarkably elevated podocyte autophagy. After treatment with N-acetylcysteine, the autophagy induced by Aldo or H2O2 was markedly attenuated, suggesting a key role of ROS in mediating autophagy formation in podocytes. Inhibition of ROS could also lessen Aldo-induced podocyte injury. Taken together, our findings suggest that ROS-triggered autophagy played a protective role against Aldo-induced podocyte injury, and targeting autophagy in podocytes may represent a new therapeutic strategy for the treatment of podocytopathy.
- Open Access
- 1 January 2016
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2016 (1) , 9045736
Demethoxycurcumin Preserves Renovascular Function by Downregulating COX‐2 Expression in Hypertension
Hypertension‐associated endothelial dysfunction is largely due to the exaggerated vasoconstrictor generation by cyclooxygenase‐2 (COX‐2). COX‐2 is induced under inflammatory condition. Demethoxycurcumin (DMC) is a major component of Curcuma longa L, which possesses anti‐inflammatory action. This study aimed to examine whether DMC protects endothelial function in hypertension by modulating COX‐2. Changes in isometric tension showed that in vivo and ex vivo treatment with DMC rescued the attenuated endothelium‐dependent relaxations (EDRs) and elevated endothelium‐dependent contractions (EDCs) in the renal arteries of SHR, which were also corrected by acute usage of the COX‐2 inhibitor celecoxib. The restoration of renovascular activity by DMC was accompanied by the normalization of COX‐2 expression. The enhanced COX‐2 expression observed in the renal arteries of hypertensive patients was suppressed by incubation of excised arteries with DMC for 12 hrs. In the renal arteries of Wistar‐Kyoto rats (WKY), DMC prevented the endothelial dysfunction caused by angiotensin II. The reduction in the generation of nitric oxide (NO) and expression of eNOS phosphorylation (Ser1177) in human umbilical vein endothelial cells caused by angiotensin II (Ang II) were restored by DMC or celecoxib. Our findings suggest that DMC may decrease COX‐2 expression and improve endothelial function in hypertension.
- 1 January 2016
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2016 (1) , 9045736
Open AccessDemethoxycurcumin Preserves Renovascular Function by Downregulating COX‐2 Expression in Hypertension
Hypertension‐associated endothelial dysfunction is largely due to the exaggerated vasoconstrictor generation by cyclooxygenase‐2 (COX‐2). COX‐2 is induced under inflammatory condition. Demethoxycurcumin (DMC) is a major component of Curcuma longa L, which possesses anti‐inflammatory action. This study aimed to examine whether DMC protects endothelial function in hypertension by modulating COX‐2. Changes in isometric tension showed that in vivo and ex vivo treatment with DMC rescued the attenuated endothelium‐dependent relaxations (EDRs) and elevated endothelium‐dependent contractions (EDCs) in the renal arteries of SHR, which were also corrected by acute usage of the COX‐2 inhibitor celecoxib. The restoration of renovascular activity by DMC was accompanied by the normalization of COX‐2 expression. The enhanced COX‐2 expression observed in the renal arteries of hypertensive patients was suppressed by incubation of excised arteries with DMC for 12 hrs. In the renal arteries of Wistar‐Kyoto rats (WKY), DMC prevented the endothelial dysfunction caused by angiotensin II. The reduction in the generation of nitric oxide (NO) and expression of eNOS phosphorylation (Ser1177) in human umbilical vein endothelial cells caused by angiotensin II (Ang II) were restored by DMC or celecoxib. Our findings suggest that DMC may decrease COX‐2 expression and improve endothelial function in hypertension.